Literature DB >> 27942521

Is it time to break the fast?-a paradigm shift in clinical lipidology.

Manuel Castro Cabezas1, Benjamin Burggraaf1, Boudewijn Klop2.   

Abstract

Year:  2016        PMID： 27942521      PMCID： PMC5124625          DOI： 10.21037/atm.2016.09.42

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  25 in total

1.  Fasting for lipid testing: is it worth the trouble?: comment on "fasting time and lipid levels in a community-based population".

Authors:  Amit V Khera; Samia Mora
Journal:  Arch Intern Med       Date:  2012-12-10

2.  The use of the non-fasting lipid profile for lipid-lowering therapy in clinical practice - point of view.

Authors:  Marijke de Vries; Boudewijn Klop; Manuel Castro Cabezas
Journal:  Atherosclerosis       Date:  2014-03-31       Impact factor: 5.162

3.  Daytime triglyceride variability in men and women with different levels of triglyceridemia.

Authors:  Boudewijn Klop; Jeffrey S Cohn; Antonie J H H M van Oostrom; Jeroen P H van Wijk; Erwin Birnie; Manuel Castro Cabezas
Journal:  Clin Chim Acta       Date:  2011-08-12       Impact factor: 3.786

4.  Tulp syndrome.

Authors:  D W Erkelens; T W de Bruin; M Castro Cabezas
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

5.  Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.

Authors:  Børge G Nordestgaard; Anne Langsted; Samia Mora; Genovefa Kolovou; Hannsjörg Baum; Eric Bruckert; Gerald F Watts; Grazyna Sypniewska; Olov Wiklund; Jan Borén; M John Chapman; Christa Cobbaert; Olivier S Descamps; Arnold von Eckardstein; Pia R Kamstrup; Kari Pulkki; Florian Kronenberg; Alan T Remaley; Nader Rifai; Emilio Ros; Michel Langlois
Journal:  Clin Chem       Date:  2016-05-27       Impact factor: 8.327

Review 6.  Hypertriglyceridemia in the genomic era: a new paradigm.

Authors:  Gary F Lewis; Changting Xiao; Robert A Hegele
Journal:  Endocr Rev       Date:  2015-01-02       Impact factor: 19.871

7.  Is abnormal postprandial lipemia a familial risk factor for coronary artery disease in individuals with normal fasting concentrations of triglycerides and cholesterol?

Authors:  K Przybycień; Z Kornacewicz-Jach; B Torbus-Lisiecka; M Naruszewicz
Journal:  Coron Artery Dis       Date:  2000-07       Impact factor: 1.439

Review 8.  A physician's guide for the management of hypertriglyceridemia: the etiology of hypertriglyceridemia determines treatment strategy.

Authors:  B Klop; J Wouter Jukema; T J Rabelink; M Castro Cabezas
Journal:  Panminerva Med       Date:  2012-06       Impact factor: 5.197

9.  Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.

Authors:  Samia Mora; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2008-08-18       Impact factor: 29.690

Review 10.  Diabetes Dyslipidemia.

Authors:  Jonathan D Schofield; Yifen Liu; Prasanna Rao-Balakrishna; Rayaz A Malik; Handrean Soran
Journal:  Diabetes Ther       Date:  2016-04-07       Impact factor: 2.945
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.